Researchers develop new diagnostic tool to detect disease-carrying mosquites
It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia. “Many of these diseases are spreading in areas where they
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XIt can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia. “Many of these diseases are spreading in areas where they
The first patients in Asia have been treated using the NeoChord procedure at Queen Mary Hospital (QMH) in Hong Kong. Cardiothoracic surgery consultants Simon Lam and Daniel Chan
XingImaging has initiated a Florbetapir PET radiotracer production network and PET acquisition to support clinical studies in China for Eisai Inc. on their MissionAD trial, global Phase 3
North Cypress Medical Center is a 139-licensed bed acute care facility in Northwest Houston. The hospital was founded by physicians dedicated to providing their community with a sophisticated,
The company has lodged a complaint against Fisher & Paykel at the US International Trade Commission to cease the infringement of its patented technology. ResMed is seeking to
Available both in the US and Europe, the microcatheters feature a system to deliver pressure-directed arterial embolization therapy. Sniper microcatheters will enhance the therapeutic agent delivery to target
Built on the HiRes Ultra platform and developed by the internal Research and Development Team at AB, the new implant is the hassle free and pain free choice
PPZs are synthetic, biofunctional macromolecules with the potential to advance a wide range of biomedical capabilities. IBBR Fellow, Dr Alexander Andrianov, is working with collaborators to develop new PPZs
An epileptic seizure is a brief episode of indications or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. The researchers have implanted the device
Established in 2004, K2M Group is engaged in the design, development and commercialization of complex spine and minimally invasive spine technologies for the treatment of complicated spinal pathologies.